BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this here.

The more prospective healthy donors we can identify as early as possible, the sooner we may be able to initiate development of this potential treatment and the more therapies we can potentially provide.

If you know of someone who has fully recovered from COVID-19 and is no longer contagious (at least 14 days post-symptoms), and who might be interested in donating their plasma to support development of a therapy that may help individuals at high-risk of COVID-19, please ask them to contact our MedInfo Center at 1-877-TAKEDA-7 (1-877-825-3327). Contacting us to learn more does not obligate individuals to donate and we will treat individual data in line with all appropriate data privacy regulations.

With the SARS-CoV-2 virus continuing to spread and cases of COVID-19 continuing to rise worldwide, we count on the support of those who have recovered to help us with our efforts to develop a potential treatment for those most at risk.